Enhanced version of CureVac’s COVID-19 vaccine could help address supply shortages

By | May 17, 2021
Researchers in Germany have demonstrated the preclinical effectiveness of a next-generation coronavirus disease 2019 (COVID-19) vaccine at enhancing antibody responses against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).